TECHNETIUM TC-99M PENTETATE KIT - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for technetium tc-99m pentetate kit and what is the scope of patent protection?
Technetium tc-99m pentetate kit
is the generic ingredient in four branded drugs marketed by Jubilant Draximage, Jubilant, Ge Healthcare, and Curium, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Two suppliers are listed for this compound.
Summary for TECHNETIUM TC-99M PENTETATE KIT
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 4 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| DailyMed Link: | TECHNETIUM TC-99M PENTETATE KIT at DailyMed |
Pharmacology for TECHNETIUM TC-99M PENTETATE KIT
| Drug Class | Lead Chelator |
| Mechanism of Action | Lead Chelating Activity |
US Patents and Regulatory Information for TECHNETIUM TC-99M PENTETATE KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant | DRAXIMAGE DTPA | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 018511-001 | Dec 29, 1989 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Curium | TECHNETIUM TC-99M PENTETATE KIT | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 215146-001 | Mar 26, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ge Healthcare | MPI DTPA KIT - CHELATE | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 017255-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ge Healthcare | TECHNETIUM TC-99M PENTETATE KIT | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 017264-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
